kids throat (Natures Investment Holdings Pty Ltd dba Maxrelief USA)


Welcome to the PulseAid listing for the kids throat drug offered from Natures Investment Holdings Pty Ltd dba Maxrelief USA. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Natures Investment Holdings Pty Ltd dba Maxrelief USA
NON-PROPRIETARY NAME: Aconite 30C, Belladonna 30C, Chamomilla 30C, Phytolacca 30C
SUBSTANCE NAME: ACONITUM NAPELLUS; BELLADONNA LEAF; MATRICARIA RECUTITA; PHYTOLACCA AMERICANA ROOT
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LOZENGE
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2014-02-12
END MARKETING DATE: 0000-00-00


kids throat HUMAN OTC DRUG Details:

Item Descriptionkids throat from Natures Investment Holdings Pty Ltd dba Maxrelief USA
LABELER NAME: Natures Investment Holdings Pty Ltd dba Maxrelief USA
DEA SCHEDULE:
ACTIVE STRENGTH: 30; 30; 30; 30([hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1)
START MARKETING DATE: 2014-02-12
END MARKETING DATE: 0000-00-00
PRODUCT ID: 76509-100_64217008-f13d-4ad5-8ec0-1b815a18876f
PRODUCT NDC: 76509-100
APPLICATION NUMBER:

Other ACONITUM NAPELLUS; BELLADONNA LEAF; MATRICARIA RECUTITA; PHYTOLACCA AMERICANA ROOT Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
KEYSUN PTY. LIMITED Also Traded as KEYSUN LABORATORIESkids throat
Natures Investment Holdings Pty Ltd dba Maxrelief USAkids throat